1. Introduction
Sporotrichosis is an affection of great importance to public health since human infection can occur through direct contact with contaminated soil organic matter (sapronosis) or, more frequently, by the zoonotic route through the domestic feline [
1,
2]. In this last scenario, the incriminated fungus is
Sporothrix brasiliensis, the highest virulent and pathogenic species of the
Sporothrix genus, with strong evidence of drug resistance [
3,
4]. The
S. brasiliensis-zoonotic transmitted sporotrichosis began as an outbreak in the late 1990s in Rio de Janeiro, Brazil, and currently is considered a nationwide hyperendemic [
5,
6] with reports of recent geographical expansion to other Latin American countries [
7,
8]. Recently, the first three cases of domestic feline-transmitted
S. brasiliensis outside South America were described in the United Kingdom, Europe [
9].
Itraconazole is the drug of choice for human and feline sporotrichosis [
10,
11]. However, the cat’s treatment remains a challenge for the veterinarian, given the limited number of antifungal agents, their high cost and adverse effects, and their commercial presentations. Moreover, little is known about the immune response triggered by the infected hosts, especially the domestic feline [
1,
11].
In this direction, the expansion of studies that aim to expand information related to the pathogen-host interaction is necessary. To this end,
Galleria mellonella stands out as an invertebrate model for the investigation of the immune response triggered by distinct fungal pathogens such as yeast of the
Candida genus [
12,
13] and
Cryptococcus neoformans [
14]. Among filamentous fungi,
Aspergillus niger, Rhizopus spp. and
Rhizomucor spp. have also been challenged against the invertebrate biomodel’s defense [
15,
16,
17], as have also the dimorphic
Paracoccidioides lutzii and
Histoplasma capsulatum [
18,
19]. However, few studies were dedicated to the interaction between
G. mellonella and fungi of the
Sporothrix genus, all focusing on phenotypic aspects to investigate the host-pathogen interaction [
20,
21,
22] or
in vivo drug-response [
23].
The
G. mellonella immune system has close both structural and functional similarities to the mammalian innate immune system [
24,
25], and is divided into two strongly interconnected pathways: the cell-mediated pathway and the humoral pathway [
26]. The cellular response of insects is mediated by hemocytes, phagocytic cells in the hemolymph. These have the function of phagocytosing foreign bodies, capturing and encapsulating them in multicellular structures called nodules or capsules [
26,
27,
28]; playing roles analogous to those of human macrophages and neutrophils [
24,
25]. In parallel, the humoral response of insects includes antimicrobial peptides (AMPs), which act directly against invaders. Among the
G. mellonella AMPs, gallerimycin and galiomycin are the most well-described in the literature [
29], with evidence of positive regulation on gene expression in fungal infections, such as
Candida spp. and
Aspergillus niger by this insect [
17,
30,
31].
In a complementary investigation, other parameters such as the role of stress-managing genes can be evaluated during the immune response of the larvae against pathogens [
30]. Among the best-characterized ones are those responsible for the regulation of cytokines (
C7 Contig 15362), those linked to the phagocytosis and related to protein binding (
C8 Contig 19101) and those involved in inflammatory responses (
C3- Contig 15265, C4- Contig 290595, C5- Contig 21310, C6- Contig 1327) [
30,
32,
33].
Data about the cellular and humoral insect defenses during the infectious process can provide new information on the host-pathogen interaction. Furthermore, elucidating mechanisms of S. brasiliensis infection in the invertebrate model may contribute to the future detection of new therapeutic targets as well as to the description of promising molecules to control this mycosis. Thus, the objective of the present study was to monitor G. mellonella's phenotypic and genotypic responses against S. brasiliensis. To the best of our knowledge, the present study is the first to evaluate the defense-related gene expression of G. mellonella in response to infection by a dimorphic fungus.
4. Discussion
Although sporotrichosis is a disease of great importance in public health, numerous aspects of the pathogen-host relationship are yet to be elucidated, mainly for the main host of this zoonosis, the domestic feline [
1,
39]. As a matter of fact, such an investigation requires an appropriate experimental model. For decades, the murine model has been used as the
in vivo gold standard model for pathogenicity mechanisms of distinct microorganisms [
40], including
Sporothrix spp [
41]. However, recently, the scientific community has been showing ethical and social concerns, applied to the rationalization of animal model use [
29,
42,
43].
Therefore, aiming at obtaining an alternative approach to mammalian models, several invertebrate models of infection have been studied, with emphasis on
Galleria mellonella [
44,
45]. In spite of the previous use of this insect for the investigation of different fungal and bacterial infections [
19,
46], studies concerning the
Sporothrix genus pathogenicity are still limited. As a matter of fact, only four previous studies investigated
S. brasiliensis-G. mellonella binomial, based on the description of phenotypic aspects [
20,
21,
22,
23]. Therefore, this is the first study to draw a parallel between
G. mellonella inate immunity-related gene expression and deleterious events during
Sporothrix infection.
The results obtained on the survival curve of
S. brasiliensis infection
in G. mellonella standardization showed that the ideal yeast inoculum (1x10
7 yeast/larva) and temperature (37°C) were partially similar to those described by Clavijo-Giraldo and collaborators [
21]. For more efficient killing by the fungal pathogen, these authors concluded that temperatures closer to the natural mammalian host are required to maintain all virulence attributes expressed by the yeast morphology. However, a less concentrated inoculum of 1x10
5 yeast/larvae was sufficient for these authors to obtain an appropriate survival curve. It is believed that this difference may be related mainly to the lineage of the larva used or even uncontrolled environmental conditions. On the other hand, Freitas and co-authors [
20] used the same fungal load of 1x10
7 yeast/larva, since when testing lower concentrations (1x10
4 yeast/larva and 1x10
6 yeast/larva), they did not observe mortality in the survival curve. In addition, the temperature of 37°C was also recommended for the experiment, corroborating in both aspects with the results obtained here.
Daily monitoring of
S. brasiliensis load during the infection curve provided progressive increasing values ranging from 1.2x10
4 to 4x10
5 CFU per animal. An average fungal load ranging from 1.8x10
5 to 2.4x10
5 CFU per animal was previously described [
22] after 24 hours of infection. Gandra and colleagues [
31] observed that by inoculating 1x10
7 Candida albicans/larvae, CFUs ranged from 1.0x10
8 to 1.0x10
12 at 6, 24, and 48 hours. These data reinforce the suitability of
G. mellonella as a model of yeast infection since it differentially mirrors
Candida and
Sporothrix fungal loads increase, such as previously described for mammalian hosts [
47,
48].
It is noteworthy to mention the proportional increase of hemocytes in response to
S. brasiliensis's higher fungal loads, beginning on the fifth day of the curve. As a matter of fact, on the fifth day the major phenotypic event registered was the beginning of larvae death. Thus, it is possible to hypothesize that larvae morbidity is a result of higher fungal loads as the immune system, although proportionally stimulated reaching greater hemocyte recruitment, fails [
26,
49].
Lozoya-Pérez and collaborators [
22] described a similar
S. brasiliensis-
G. mellonella approach, at a single-specific point of the survival curve. CFU and hemocyte counting from the insect's hemolymph were obtained 24 hours after yeast inoculation, previously grown in distinct culture media. CFU values between 1.8x10
5 and 2.4x10
5 were found and 3.9 and 9.2 ×10
6 hemocytes/mL, depending on the culture medium used. Such values were lower than those found in the present study (6.4x10
6 to 3.0x10
7 hemocytes/mL). This difference may be related to the 100x higher
S. brasiliensis inoculated in the present study protocol.
In spite of the increasing amount of literature involving the use of
G. mellonella as an invertebrate biomodel, little is known about its defense strategies against
S. brasiliensis. Even though the present study was able to establish a comparison with the previous work concerning the phenotypic events of the
Sporothrix-
G. mellonella interaction [
21,
22,
50] we are limited to few previous publications approaching the molecular aspects of the
S. schenckii infection [
50]. Actually, gene expression data in such experimental scenario is limited to the genus
Candida [
31,
44].
To the best of our knowledge this is the first study to investigate G. mellonella phenotypic and molecular events triggered by the infection with the most virulent Sporothrix species, S. brasiliensis. In contrast, a considerable number of published works is available on the G. mellonella humoral response to Candida species. These quantify the expression of AMPs promoter genes with distinct purposes, among them the description of the larval immune response profiles under different infection protocols and the evaluation of potential antimicrobial drugs. By respecting the differences inherent to each fungal species, these findings were used as parameters in order to discuss the present study findings.
Given the previous works highlighting the importance of the
G. mellonella AMPs encoding genes
Gallerimycin and
Galiomycin, during both filamentous and yeast fungal infections [
29,
31] this study seeked to quantify these genes expression after the infection by the dimorphic fungus
Sporothrix brasiliensis. While
Gallerimycin presented an expressive increase in gene expression along the survival curve,
Galiomycin remained inaltered. These results suggest that the AMP Gallerimycin plays a relevant role in the insect’s response to
S. brasiliensis infection, as previously described during
Candida spp. infection [
31,
51]. Contrarily, Dekkerová-Chupáčová and co-authors [
12] observed that the inoculation of 2x10
5 yeast/larvae of
C. albicans and
C. dubliniensis into
G. mellonella larvae triggered an expressive increase in AMP coding genes, especially
Galiomycin.
The differential relevance of the
G. mellonella Galiomycin gene expression during
Candida albicans and dubliniensis versus
S. brasiliensis infections may be explained by the fact that the first is a well know microbiota yeast member interacting with vertebrates during millions of years of evolution while
Sporothrix species evolved from saprophytic mycelial fungi recently adapted to parasitism by termodimorphism. Therefore,
Sporothrix species may be in the process of gene expression adapting to the animal organic matter [
2,
52].
In addition to positive regulation, time-dependent regulation was observed, and
Gallerimycin evidenced a significant increase on days D1 and D8. Such a result partially corroborates with that found by Dekkerová-Chupáčová and co-authors [
12]. They noted that the maximum up-regulation of both genes was shown at 24 h post-infection, but as early as one hour into the infection, a positive regulation of expression was already observed. More specifically, the gene encoding
Gallerimycin was up to 1.3-fold higher (1 h post-infection) and 3.2-fold higher (24 h post-infection) in larvae infected with
C. albicans compared to
C. dubliniensis. Whereas for
Galiomycin we observed up to 3.7-fold (1 h post-infection) and 7.1-fold (24 h post-infection) relative up-regulation in
C. albicans-infected larvae. The up-regulation of both genes decreased at 48 h post-infection by these two species.
In this regard, the difference in gene expression analysis intervals was based on the metabolic characteristics of the fungal species.
Candida spp. demonstrates considerably faster growth both
in vitro and
in vivo, in the invertebrate model itself, compared to
Sporothrix spp. [
13]. Moreover, given the scarcity of information regarding the gene expression of
G. mellonella against
Sporothrix spp., the choice of day (D) for gene expression analysis was defined according to the defense phenomena of the larvae observed in response to the fungus, such as melanization, mobility changes, and the onset of mortality.
Concerning the results observed in the expression of stress management genes,
C7 Contig 15362 and
C8 Contig 19101 showed a significant difference in gene expression between the experimental groups on the fifth day (D5) of infection. Drawing a parallel with the study conducted by Melo and collaborators [
30] evaluating
G. mellonella gene expression after
C. albicans infection versus different antifungal therapies, in 24 and 48 hours, it was also possible to observe a positive regulation of both genes in the infected, untreated larvae. A relevant point is that in this case
C8 Contig 19101, was about 4 times overexpressed than C7
Contig 15362 gene.
In the present study, it was possible to observe that the expression of the genes studied is not only time-dependent but also alternately modulated. Since, when comparing the genes responsible for encoding AMPs with those of stress management, this significant increase D-day varied.
C7 Contig 15362 and
C8 Contig 19101 are considered stress management genes and showed a significant increase in expression on day 5 post-infection. Interestingly, this moment coincides with the onset of mortality and deleterious phenotypic changes observed during the survival curve, as well as with the beginning of the expressive increase in defense cells and fungal load. In contrast, genes encoding AMPs, especially
Gallerimycin, showed an immediate response verified by the intense mRNA encoding as early as the first post-infection day. This finding is compatible with the participation of the AMPs, previously characterized as an early element of humoral immunity against the infectious process [
53,
54]. For this same fact, different authors determine evaluation protocols in hours, both in the investigation of the infectious process by
Candida spp. [
12,
31,
51] and by
Aspergillus niger [
17].
This work is the first to evaluate the gene expression related to the defense of the insect
G. mellonella in response to infection by a dimorphic fungus. Most authors have dedicated themselves to the investigation of yeasts and, among these, of the genus
Candida [
12,
30,
31]. Among the filamentous fungi, previous investigation considered
Aspergillus niger [
17] and
Fusarium oxysporum [
55].
The possibility that filamentations occurred during the infectious process in
G. mellonella cannot be excluded. Thus, the comparative discussion of some of the parameters evaluated here is limited. It is important to add the fact that previously the presence of hyphae of
S. brasiliensis has been reported, both
in vitro in feline phagocytes [
56] and either during human or animal parasitism (manuscript in preparation). It is known that the fungal cell wall undergoes profound transformation altering, during the dimorphic transition, β-1-3-glucans to α-glucans posing an immediate challenge to the host immune response (PAMPs) [
17,
57]. However, only studies that consider distinct periods within the survival curve will be able to answer whether the verified gene expression was exclusively yeast-triggered and or yeast-targeted.
Another acknowledged limitation is the absence of data regarding gene expression in the intervals between the defined days. However, because this is a pioneer investigation in the area, new perspectives and methodologies can be generated and improved in order to overcome the scarcity of data in the literature and elucidate the aspects of this relevant pathogen-host interaction. The present work opens new doors of investigation on the pathogenesis by Sporothrix spp. as well as offers a better characterized model for the research of potential antifungal drugs effective for the control of this important zoonosis.
Author Contributions
Conceptualization, N.F.R, R.L.D.M, H.M.M-M. and A.R.S.B; Methodology, N.F.R, M.C.S.J, J.A.C.R. and L.C.S.V.S; Software, J.R.S.S and M.C.S.J.; Validation, N.F.R, L.M.A and H.M.M-M.; Formal Analysis, P.A.P., C.S.V, H.M.M-M., R.L.D.M.; Investigation, N.F.R., M.C.S.J., J.A.C.R. and S.C.P.B; Resources, A.R.S.B, P.A.P. and R.L.D.M.; Data Curation, N.F.R, M.C.S.J and A.R.S.B; Writing – Original Draft Preparation, N.F.R, M.C.S.J. and A.R.S.B; Writing – Review & Editing, A.R.S.B, B.A.P and H.M.M-M.; Visualization, H.M.M-M.; Supervision, A.R.S.B, B.A.P, P.A.P and C.S.V; Project Administration, A.R.S.B and R.L.D.M; Funding Acquisition, A.R.S.B, B.A.P and R.L.D.M. All authors have read and agreed to the published version of the manuscript.